Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kavanagh

Showing results (581-590 of 764) with videos related to

Pageof 77
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Protection of acute myeloblastic leukemia cells against apoptotic cell death by high glutathione and gamma-glutamylcysteine synthetase levels during etoposide-induced oxidative stressT Siitonen, P Alaruikka, P Mäntymaa, et al.
Cancer|December 18, 2001
Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervixC F Verschraegen, J J Kavanagh, E Loyer, et al.
European Journal of Gynaecological Oncology|January 1, 1996
Paclitaxel retreatment in patients with platinum and paclitaxel resistant ovarian cancerD Tresukosol, A P Kudelka, C Gonzales de Leon, et al.
The Journal of Reproductive Medicine|June 1, 1996
Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumorA Fishman, A P Kudelka, D Tresukosol, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|April 1, 1996
Paclitaxel in patients with platinum-resistant ovarian cancer: a selected review of literature and clinical experienceA P Kudelka, D Tresukosol, C Gonzalez de Leon, et al.
Cancer Chemotherapy and Pharmacology|October 31, 2003
A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecanClaire F Verschraegen, Andrzej P Kudelka, Wei Hu, et al.
Free Radical Biology & Medicine|August 4, 2004
Glutamate-cysteine ligase attenuates TNF-induced mitochondrial injury and apoptosisDianne Botta, Christopher C Franklin, Collin C White, et al.
Substance Use & Misuse|April 7, 2018
An Examination of Gender Differences in the Association of Adolescent Substance use with Eating and Weight Loss AttitudesRebekah L Thomas, Adrian B Kelly, Gary C K Chan, et al.
Plos One|April 24, 2026
Correction: Formative research for a pre-operative psychosocial screening program for cardiac surgical patients: The EMBRACE study, a mixed methods knowledge to action protocolSusan E Smith, Marlien Varnfield, David J Kavanagh, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|March 31, 2012
Fathead minnow (Pimephales promelas) reproduction is impaired when exposed to a naphthenic acid extractRichard J Kavanagh, Richard A Frank, B Kent Burnison, et al.
Pageof 77

Showing results (581-590 of 764) with videos related to

Sort By:
Pageof 77
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Protection of acute myeloblastic leukemia cells against apoptotic cell death by high glutathione and gamma-glutamylcysteine synthetase levels during etoposide-induced oxidative stressT Siitonen, P Alaruikka, P Mäntymaa, et al.
Cancer|December 18, 2001
Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervixC F Verschraegen, J J Kavanagh, E Loyer, et al.
European Journal of Gynaecological Oncology|January 1, 1996
Paclitaxel retreatment in patients with platinum and paclitaxel resistant ovarian cancerD Tresukosol, A P Kudelka, C Gonzales de Leon, et al.
The Journal of Reproductive Medicine|June 1, 1996
Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumorA Fishman, A P Kudelka, D Tresukosol, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|April 1, 1996
Paclitaxel in patients with platinum-resistant ovarian cancer: a selected review of literature and clinical experienceA P Kudelka, D Tresukosol, C Gonzalez de Leon, et al.
Cancer Chemotherapy and Pharmacology|October 31, 2003
A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecanClaire F Verschraegen, Andrzej P Kudelka, Wei Hu, et al.
Free Radical Biology & Medicine|August 4, 2004
Glutamate-cysteine ligase attenuates TNF-induced mitochondrial injury and apoptosisDianne Botta, Christopher C Franklin, Collin C White, et al.
Substance Use & Misuse|April 7, 2018
An Examination of Gender Differences in the Association of Adolescent Substance use with Eating and Weight Loss AttitudesRebekah L Thomas, Adrian B Kelly, Gary C K Chan, et al.
Plos One|April 24, 2026
Correction: Formative research for a pre-operative psychosocial screening program for cardiac surgical patients: The EMBRACE study, a mixed methods knowledge to action protocolSusan E Smith, Marlien Varnfield, David J Kavanagh, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|March 31, 2012
Fathead minnow (Pimephales promelas) reproduction is impaired when exposed to a naphthenic acid extractRichard J Kavanagh, Richard A Frank, B Kent Burnison, et al.
Pageof 77